TECHNOLOGICAL NEW ANTINEOPLASTIC APPLICATIONS (Q2031453)

From EU Knowledge Graph
Revision as of 09:22, 23 March 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): THE UNITS OF CHEMICAL AND PHARMACEUTICAL SCIENCE (DSCF) AND LIFE SCIENCES (DSV) HAVE DIFFERENTIATED AND COMPLEMENTARY SKILLS AND ROLES. UNITS-DSCF CURRENT THE DESIGN, SYNTHESIS AND MODIFICATION OF NEW DEUBILIQUITINASI (ISISIDASEI) INHIBITORS WHICH ARE STRUCTURALLY RELATED TO THIS 2CPE INHIBITOR, THE ACTIVITY OF WHICH HAS BEEN RECENTLY DEMONSTRATED IN VITRO AND IN VIVO. THE DESIGN OF SECOND GENERATION INHIBITORS WILL INFORM THE, Adding English...)
Jump to navigation Jump to search
Project in Italy financed by DG Regio
Language Label Description Also known as
English
TECHNOLOGICAL NEW ANTINEOPLASTIC APPLICATIONS
Project in Italy financed by DG Regio

    Statements

    0 references
    152,000.0 Euro
    0 references
    304,000.0 Euro
    0 references
    50.0 percent
    0 references
    22 July 2016
    0 references
    30 April 2019
    0 references
    DIPARTIMENTO DI SCIENZE CHIMICHE E FARMACEUTICHE
    0 references
    0 references

    45°40'37.52"N, 13°45'12.31"E
    0 references
    UNITS PARTECIPERà AL PROGETTO CON I DIPARTIMENTI DI SCIENZE CHIMICHE E FARMACEUTICHE (DSCF) E DI SCIENZE DELLA VITA (DSV), CON COMPETENZE E RUOLI DIFFERENZIATI E COMPLEMENTARI. UNITS-DSCF CURERà LA PROGETTAZIONE, SINTESI E MODIFICA DI NUOVI INIBITORI DI DEUBIQUITINASI (ISOPEPTIDASI) STRUTTURALMENTE COLLEGATI ALL¿INIBITORE 2CPE, LA CUI ATTIVITà ANTINEOPLASTICA Ê STATA RECENTEMENTE DIMOSTRATA IN VITRO E IN VIVO. LA PROGETTAZIONE DI INIBITORI DI SECONDA GENERAZIONE TERRà CONTO DI INFORMA (Italian)
    0 references
    THE UNITS OF CHEMICAL AND PHARMACEUTICAL SCIENCE (DSCF) AND LIFE SCIENCES (DSV) HAVE DIFFERENTIATED AND COMPLEMENTARY SKILLS AND ROLES. UNITS-DSCF CURRENT THE DESIGN, SYNTHESIS AND MODIFICATION OF NEW DEUBILIQUITINASI (ISISIDASEI) INHIBITORS WHICH ARE STRUCTURALLY RELATED TO THIS 2CPE INHIBITOR, THE ACTIVITY OF WHICH HAS BEEN RECENTLY DEMONSTRATED IN VITRO AND IN VIVO. THE DESIGN OF SECOND GENERATION INHIBITORS WILL INFORM THE (English)
    0 references

    Identifiers

    J96G17000120005
    0 references